CD4+T cells mediate systemic and local immune changes and pain symptoms in the rat model of temporomandibular disorders related pain Authors: Jianquan He, Yuzhuo Hei, Lin Li, Xiaojun Xia, Zhihui Mai, Xiayun Chen Published: 2026 ABSTRACT Background and purposeImmune cells involved in pain has received increasing attention, but the available literature on the role of T cells in temporomandibular disorders (TMD) related pain is limited. Our previous study has showed that elevated expression of HLA DR+ CD4+ T cell may increase the risk of TMD-related pain. In the present study, we aimed to investigate CD4+ T cell-mediated systemic and local immune changes in the rat model of TMD-related pain via CD4+ T cell depletion, and clarify the immunological contribution of CD4+ T cell on TMD-related pain.MethodsA rat model of occlusal interference was established to induce TMD-related pain. Animals were divided into three Groups: control (Group1), occlusal interference (Group2), and occlusal interference with CD4⁺ T cell depletion (Group3). Systemic CD4⁺ T cell proportions were verified by flow cytometry at day3, 6, 14. Pain-related behavior was assessed by von Frey testing daily, and the circulating levels of cortisol, TNF-α, IL-6, IL-17 A, and IFN-γ levels quantified by ELISA at day 3, 10, 15. In the end, local inflammatory cytokine expression patterns in condylar tissues were examined by immunofluorescence staining.ResultsOcclusal interference model successfully mimicked significant TMD-related pain with a sharply increase reaching its peak at day 6 followed by a gradual decline, but at lower level of pain in Group3. The circulating level of IL-17 A rapidly rise at the initial phase, then stabilized and declined eventually despite of CD4⁺ T cell depletion or not. Levels of cortisol and TNF-α were significantly decreased at the end of the study in Group 3. Immunofluorescence analysis of condylar tissues revealed substantial up-regulation of TNF-α, IL-6 and IFN-γ in Group 2, which was significantly alleviated in Group 3.ConclusionThis study demonstrated IL-17 A increased with pain independent of CD4+T cells at the early stage. But consistently lower pain sensitivity, reduced systemic and local inflammatory cytokines in the later were identified after CD4 + T cell depletion. So we suggest that CD4⁺ T cells are important to maintain TMD-related pain and central to the late-phase immunological cascade in this model. More underlying mechanism of CD4⁺ T cells involved in TMD-related pain warrant further investigations.Supplementary InformationThe online version contains supplementary material available at 10.1186/s10194-026-02422-y. Introduction The temporomandibular joint (TMJ) plays a crucial role in jaw movement and functions like chewing and speaking. Its unique structure and function subjected to cyclic loading make it more vulnerable [1]. Typical symptoms of temporomandibular disorders (TMD) are related pain, swelling and tenderness around the TMJ, limited mobility of the jaw, and noises during jaw movement [2]. It has been considered that TMD are the second most common musculoskeletal chronic pain disorder after low back pain, affecting 6–9% of adults globally [3]. Moreover, the prevalence of TMJ involvement in Rheumatoid arthritis (RA) patients has been reported to range from 19% to 86% [4, 5]. Because the high degree difference of symptom and a lack of definitive underlying etiology make TMD-related pain difficult to treat. Current intervention primarily relies on symptom management by multimodal conservative approaches, including occlusal splints, physical therapy, pharmacologic interventions, and behavioral therapy. In addition, the prognosis of TMD-related pain is uncertain and variable [6]. Emerging evidence indicates that the development and persistence of TMD-related pain are profoundly influenced by immune and inflammatory mechanisms that sustain peripheral and central sensitization [7–9]. In patients with painful TMD, elevated concentrations of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), Interferon-γ (IFN-γ), and interleukin-6 (IL-6), interleukin-17 A (IL-17 A) have been consistently detected in synovial fluid and serum, suggesting that local and systemic inflammatory activation contributes to pain [10–12]. It is now well appreciated that immune cells are integral to both physiological and pathological pain, by releasing various ligands and mediators, contributing to the initiation, modulation, persistence, or resolution of various modalities of pain [13, 14]. Within the TMJ microenvironment, macrophages and neutrophils act as major immune effectors driving nociceptive sensitization and tissue degeneration. Activated macrophages release TNF-α, IL-1β, and IL-6 and regulate chemokine networks that recruit additional immune cells, thereby promoting synovitis, cartilage breakdown, and peripheral nerve sensitization [15, 16]. Neutrophils, through the production of reactive oxygen species and proteolytic enzymes, aggravate local injury and amplify nociceptive signaling, consistent with their recognized pronociceptive roles in inflammatory pain models [17, 18]. In addition, experimental studies have demonstrated that T cell activation can drive synovitis and pain hypersensitivity, and distinct CD4⁺ T cell subsets modulate local inflammation and excitatory signaling through cytokines such as IFN-γ and IL-17 [19, 20]. However, the role of CD4⁺ T cells in the immunopathology and pain mechanisms of TMD remains poorly characterized. In our previous Mendelian randomization analysis, we found that a higher abundance of HLA-DR⁺ CD4⁺ T cells was causally associated with an increased risk of TMD-related pain [21]. Therefore, investigating the immune impact of CD4⁺ T cells on TMD-related pain may provide crucial insight into the immune-mediated processes underlying TMD-related pain. In the present study, we seek to further understand the immune mechanisms underlying CD4⁺ T cells involved in TMD-related pain and obtain useful evidence for subsequent research on potential therapeutic approaches. Materials and methods Animal A total of 15 male Sprague-Dawley (SD) rats, weighing 160–220 g, were obtained from the Guangdong Provincial Medical Laboratory Animal Center. All animals were housed in a specific pathogen-free (SPF) environment under controlled conditions (temperature: 20–26 °C; 12/12 h light-dark cycle) with ad libitum access to food and water. Prior to the experiments, the rats underwent a one-week acclimatization period to minimize stress-related effects. All experimental procedures were approved by the Animal Ethics Committee of South China Agricultural University(2025D010). Animal model Fifteen male SD rats were randomly divided into three Groups: control (Group 1; n = 5), occlusal interference (Group 2; n = 5), and occlusal interference with anti-CD4⁺ T cell antibody treatment (Group 3; n = 5). CD4⁺ T cell depletion was assessed by flow cytometry, and rats whose circulating CD4⁺ T cells were not depleted were excluded from the experiment. Notably, one rat in Group 3 exhibited no apparent reduction in CD4⁺ T cells and remained comparable to Group 2 across all three flow-cytometry assessments. According to the pre-specified exclusion criteria, this rat was excluded from all subsequent analyses; thus, the effective sample size for Group 3 was n = 4 for all outcomes. Rats in Group2 and Group3 were anesthetized via intraperitoneal injection of sodium pentobarbital (20 mg/kg). After securing the head and opening the mouth, the right maxillary first molar was isolated and dried. A dental adhesive was applied to the occlusal surface and light-cured for 10 s, followed by the application of a 1-mm-thick layer of light-curable resin, which was then polymerized using a curing light (470 nm wavelength) for 20 s. Postoperative monitoring was conducted daily to ensure the resin remained in place. On day 15, the animals were euthanized, and bilateral condylar tissues were harvested for subsequent analyses. Assessment of nociceptive behavior The mechanical pain sensitivity of the rat masseter muscle was evaluated using the Von Frey filament method, as described by Ren et al. [22]. Testing was performed at bilateral sites corresponding to the pressure-sensitive points of the masseter muscle, located approximately 1 cm posteroinferior to the midpoint between the eye and the ear. A series of calibrated nylon filaments, ranging from 5.46 to 6.10 (indicating increasing force levels) were used. Each filament was applied perpendicularly to the skin until it gently bent, which was defined as the application threshold. For each filament size, five stimulations were performed, each lasting 3–5 s, with intervals of 2–3 min between stimuli. A positive response was recorded if the rat exhibited behaviors such as head withdrawal, avoidance, limb lifting, vocalization, asymmetric facial grooming, or biting at the filament. If no response was observed with a thinner filament, progressively thicker filaments were applied. Mechanical hyperalgesia scores were quantified using a graded scoring system that integrates filament force and response frequency. Three calibrated von Frey filaments were used: 6.10 (100 g), 5.88 (60 g), and 5.46 (26 g), corresponding to score tiers of 0–1.0, 1.2–2.0, and 2.2–3.0, respectively. Each filament was applied five times; within each tier, the score increased by 0.2 per positive response (0–5 positives), generating a continuous outcome that reflects both stimulus intensity and response probability. A higher cumulative score indicates an increased mechanical allodynia. All three groups of rats were assessed one day before the procedure and then daily throughout the study period. CD4⁺ T cell depletion protocol To evaluate the role of CD4⁺ T cells in the development of occlusal interference–induced pain, a monoclonal anti-CD4 antibody (OX-38, Bio X Cell, USA) was administered intraperitoneally at a dose of 5 mg/kg for selective depletion of CD4⁺ T cells. The first antibody injection was performed at day 2. A second antibody injection was given at day10. Peripheral venous blood samples were collected for flow cytometric analysis to confirm the efficacy and duration of depletion at day3, 6, 14. Experimental timeline of the occlusal interference model, assessment and CD4⁺ T cell depletion was illustrated in Fig. 1. Fig. 1Experimental timeline of the occlusal interference model, assessment and CD4⁺ T cell depletion. Occlusal interference was induced at Day 1. Anti-CD4 antibody was administered at Days 2 and 10. Flow cytometry was performed on Days 3, 6, 14. Serum ELISA was conducted at Days 3, 10, and 15. TMJ tissues were collected at Day 15. Mechanical sensitivity was assessed daily (Days 1–15) using the von Frey test Experimental timeline of the occlusal interference model, assessment and CD4⁺ T cell depletion. Occlusal interference was induced at Day 1. Anti-CD4 antibody was administered at Days 2 and 10. Flow cytometry was performed on Days 3, 6, 14. Serum ELISA was conducted at Days 3, 10, and 15. TMJ tissues were collected at Day 15. Mechanical sensitivity was assessed daily (Days 1–15) using the von Frey test Flow cytometry T lymphocyte proportions in rat peripheral blood were analyzed using flow cytometry. Whole blood was collected via the tail vein, followed by red blood cell lysis. The remaining cells were washed twice with phosphate-buffered saline (PBS, pH 7.4) and resuspended in PBS containing 1% bovine serum albumin (BSA) to a final concentration of 1 × 10⁶ cells/mL. A 100 µL aliquot of the cell suspension was incubated with APC-conjugated anti-rat CD3 antibody (1:100 dilution) and PE-conjugated anti-rat CD4 antibody (1:100 dilution) for 30 min at 4 °C in the dark. After incubation, the cells were washed with PBS to remove any unbound antibodies. Samples were analyzed using a CytoFLEX S flow cytometer (Beckman Coulter), with PE and APC fluorophores excited by 488 nm and 640 nm lasers, respectively. Data acquisition and analysis were performed using FlowJo software (version10.8.1). The proportion of CD4⁺ T cells was calculated and expressed as a percentage of the CD3⁺ T cell parent population. ELISA Whole blood was collected from the tail vein of rats at day3, 10, 15. After centrifuged at 3500 rpm for 20 min, the supernatant (serum) was carefully collected and analyzed using ELISA kits to quantify levels of rat cortisol, TNF-α, IL-6, IL-17 A, and IFN-γ. For each assay, 100 µL of appropriately diluted serum was added to wells of pre-coated ELISA plates and incubated at 37 °C for 60 min. After incubation, the wells were emptied and blotted dry, followed by the addition of 100 µL of detection antibody and another 1-hour incubation at 37 °C. Plates were then washed five times (300 µL/well, 2-minute soak per wash). Subsequently, 100 µL of enzyme-conjugated reagent was added to each well and incubated in the dark at 37 °C for 30 min. After a second round of washing, 90 µL of TMB substrate was added to each well and allowed to develop color in the dark for 15 min at 37 °C. The reaction was stopped by adding 50 µL of stop solution, resulting in a color change from blue to yellow. Optical density (OD) was measured immediately at 450 nm using a microplate reader, and all readings were completed within 10 min. Sample concentrations were calculated using a standard curve generated by plotting known standard concentrations against corresponding OD values and applying the resulting regression equation. Immunofluorescence staining TMJ condyle tissue were processed for immunofluorescence staining. Paraffin-embedded samples were deparaffinized in xylene, rehydrated through graded ethanol, and subjected to antigen retrieval in EDTA buffer (pH 9.0). After cooling to room temperature, sections were treated with 3% hydrogen peroxide for 20 min to block endogenous peroxidase activity, followed by blocking with 10% goat serum at 37 °C for 30 min. The sections were then incubated with primary antibodies overnight at 4 °C, washed with PBS, and incubated with fluorescence-conjugated secondary antibodies (1:200) for 1 h at 37 °C in the dark. To validate the specificity of the staining, isotype controls were included in parallel, which showed no significant background signal. Nuclei were counterstained with DAPI for 5 min, and slides were mounted with anti-fade medium and stored at 4 °C in the dark until observation under a fluorescence microscope. To investigate the role of Th1 cells and the source of IL-17 A and the infiltration of Th17 cells in TMD-related pain, Immunofluorescence double staining for IL-17 A, IFN-γ and CD4⁺ T cells were performed. For quantitative analysis, biological replicates of three rats per group were used. To ensure data objectivity, image capture and analysis were conducted using a blinded approach. One representative field from the TMJ tissue of each rat was randomly selected by an independent observer blinded to the experimental groups for Integrated Optical Density (IOD) quantification. Drugs and reagents APC anti-rat CD3 antibody was obtained from Elabscience (China). PE anti-rat CD4 (domain 2) antibody was obtained from BioLegend (USA). Anti-rat CD4 antibody was obtained from Bio X Cell (USA). Enzyme-linked immunosorbent assay (ELISA) kits for rat cortisol, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-17 A (IL-17 A), and interferon-gamma (IFN-γ) were obtained from Jianglai Biotechnology (China), primary antibodies against IL-6 (Servicebio, China), TNF-α (Bioss, China), IL-17 A (Proteintech, USA), CD4 (Abcam, UK), and IFN-γ (Bioss, China) were used. Statistical analysis Statistical analyses were conducted using GraphPad Prism version 10.6.1. All quantitative data are expressed as the mean ± standard deviation (SD). The specific statistical tests applied were chosen based on the experimental design. For comparisons among three groups at a single time point, a one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test was utilized. For the assessment of mechanical pain sensitivity, a two-way repeated-measures ANOVA was performed. A two-tailed P value of less than 0.05 was considered statistically significant. Results Effect of CD4⁺ T cell depletion on mechanical hypersensitivity in the rat model of occlusal interference–induced TMD-related pain In this study, occlusal interference models of Group2 and Group3 were established to induce TMD-related pain, according to previously validated experimental protocol [23]. Rats in Groups 2 and 3 exhibited evident signs of discomfort, including reduced spontaneous activity and altered chewing behavior. These manifestations are consistent with previously reported behavioral changes in occlusal interference models, reflecting stress and pain responses associated with abnormal occlusal loading. Mechanical hypersensitivity was assessed by determining the orofacial mechanical hyperalgesia scores using von Frey filaments, a well-established method for evaluating pain sensitization. A similar change pattern was displayed, with an initial increase in mechanical hyperalgesia score reaching a peak at day6, followed by a gradual decline. However, rats in Group 3 exhibited significantly lower mechanical hyperalgesia score all the time. Specific mechanical hyperalgesia scores changes are illustrated in Fig. 2. These findings suggest that although the overall temporal pattern of pain response was comparable between Groups, depletion of CD4⁺ T cells consistently reduced mechanical score, indicating that CD4⁺ T cells may contribute to the modulation of TMD-related pain induced by occlusal interference. Fig. 2Mechanical pain sensitivity of the masseter muscle was assessed daily in the three groups. Mechanical hyperalgesia scores were calculated based on the number of positive responses and the corresponding filament strength, with higher scores indicating increased mechanical hypersensitivity. Data are shown as mean ± SD. Statistical significance was determined using a two-way repeated-measures ANOVA. ****p < 0.0001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) Mechanical pain sensitivity of the masseter muscle was assessed daily in the three groups. Mechanical hyperalgesia scores were calculated based on the number of positive responses and the corresponding filament strength, with higher scores indicating increased mechanical hypersensitivity. Data are shown as mean ± SD. Statistical significance was determined using a two-way repeated-measures ANOVA. ****p < 0.0001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) T lymphocyte proportions in rat peripheral blood using flow cytometry following Anti-CD4 antibody administration Peripheral blood CD4⁺ T cell proportions were analyzed by flow cytometry to evaluate the efficacy of anti-CD4 antibody treatment at day 3,6,14. At the first assessment, CD4⁺ T cell percentages in Group 3 exhibited a marked reduction to 0.4%, indicating that antibody administration rapidly achieved efficient cell depletion, whereas, no significant differences were observed in Group 1 and Group 2, both remaining at baseline levels (Fig. 3A, D). At the second assessment, the CD4⁺ T cell proportion in Group 2 was elevated compared with Group 1, potentially reflecting CD4⁺ T cell activation and proliferation in response to sustained inflammatory stimulation; conversely, it maintained low proportion in Group 3, demonstrating the persistent effectiveness of the antibody (Fig. 3B, E). At the third assessment, it still maintained at lower CD4⁺ T cell levels in Group 3, further confirming that repeated anti-CD4 antibody administration maintained robust and durable cell depletion (Fig. 3C, F). Fig. 3CD4⁺ T cell depletion efficiency was assessed by flow cytometry at three experimental time points. Panels (A, D), (B, E), and (C, F) represent the first, second, and third assessments, respectively, with each pair showing the flow cytometry dot plot and its corresponding quantitative bar graph. Data are presented as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, ****p < 0.0001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) CD4⁺ T cell depletion efficiency was assessed by flow cytometry at three experimental time points. Panels (A, D), (B, E), and (C, F) represent the first, second, and third assessments, respectively, with each pair showing the flow cytometry dot plot and its corresponding quantitative bar graph. Data are presented as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, ****p < 0.0001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) Temporal changes of proinflammatory cytokine expression following CD4⁺ T cell depletion at the circulating level At the first ELISA test at day 3, Serum IL-17 A concentrations were significantly elevated both in Group2 and Group3, whereas Cortisol, IFN-γ, IL-6, and TNF-α remained at baseline levels, indicating an early, IL-17 A–driven inflammatory activation (Fig. 4A, D). At the second ELISA test at day 10, IL-17 A levels declined and no differences were found between groups, and Cortisol, IFN-γ, IL-6, and TNF-α also showed no significant intergroup differences (Fig. 4B, D). At the third ELISA test at day 15, IL-17 A levels were significantly declined in Group2 and Group3 and no differences were found between them. In the meantime, TNF-α and cortisol expression increased significantly in Group 2 compared with that of in Group3 (Fig. 4C, D). Fig. 4Serum pro-inflammatory cytokines and cortisol levels measured by ELISA at three time points. (A–C) Bar plots showing the concentrations of IL-6, TNF-α, IL-17 A, and IFN-γ measured by ELISA across three independent time points in each group. Each cytokine is presented separately. (D) Serum cortisol levels quantified at the same three time points using ELISA, presented as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, ***p < 0.001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) Serum pro-inflammatory cytokines and cortisol levels measured by ELISA at three time points. (A–C) Bar plots showing the concentrations of IL-6, TNF-α, IL-17 A, and IFN-γ measured by ELISA across three independent time points in each group. Each cytokine is presented separately. (D) Serum cortisol levels quantified at the same three time points using ELISA, presented as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, ***p < 0.001. n = 5 (Groups 1–2) and n = 4 (Group 3; one rat excluded) Immunofluorescence staining of pro-inflammatory cytokines within TMJ condyle tissues Immunofluorescence analysis showed that a weak IL-6 (Fig. 5A, B) and TNF-α (Fig. 5C, D) signals (red) were detected in the TMJ subchondral bone marrow in Group3. Whereas in Group 2, there signals are much more robust. Immunofluorescence double staining indicated that in Group 3, minimal CD4+ signal (green) and IL-17 A (Fig. 5E, F) / IFN-γ (Fig. 5G, H) signal (red) were scattered in the TMJ subchondral bone marrow. Conversely, in Group 2, CD4+ and IFN-γ were abundantly infiltrated in the same area. Quantitative analysis showed IL-6, TNF-α, and IFN-γ signals were significantly increased in Group 2, whereas significantly reduced in Group 3 following CD4⁺ T cell depletion. In contrast, IL-17 A did not show a significant difference among the three groups. Synchronized with these cytokine changes, the percentage of CD4⁺ T cells in the TMJ subchondral bone marrow were markedly reduced in Group 3 (Fig. 5I). Fig. 5Immunofluorescence staining for (A) IL-6, (C) TNF-α, (E) IL-17 A, (G) IFN-γ, and (E, G) CD4⁺ in TMJ subchondral bone marrow (IL-6, TNF-α, IL-17 A, IFN-γ, red; DAPI, blue; CD4+, green) and their corresponding integrated optical density within TMJ subchondral bone marrow is quantified in (B, D,F, H,I). Magnification ×40. Scale bar = 50 μm. n = 3. Data are shown as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 Immunofluorescence staining for (A) IL-6, (C) TNF-α, (E) IL-17 A, (G) IFN-γ, and (E, G) CD4⁺ in TMJ subchondral bone marrow (IL-6, TNF-α, IL-17 A, IFN-γ, red; DAPI, blue; CD4+, green) and their corresponding integrated optical density within TMJ subchondral bone marrow is quantified in (B, D,F, H,I). Magnification ×40. Scale bar = 50 μm. n = 3. Data are shown as mean ± SD. Statistical significance was determined using a one-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 Discussion This study consistently revealed that depletion of CD4⁺ T cells effectively suppressed TMD-related pain and markedly changed both local and systemic inflammatory responses. To our knowledge, this is the first time to investigate the role of CD4⁺ T cells in TMD-related pain on the rat model. Behavioral assessments revealed a significant decrease in the mechanical hypersensitivity following CD4⁺ T cell depletion, indicating a clear reduction in pain sensitivity. ELISA and immunofluorescence analyses further confirmed that pro-inflammatory cytokines, including IL-17 A and TNF-α, were changed in serum sequentially and IL-6, INF-γ and TNF-α were significantly reduced in TMJ tissues after CD4⁺ T cells depletion. These findings suggest that CD4⁺ T cells play an important role in maintaining TMD-related pain, and their removal may disrupt the positive feedback loop between inflammation and neuronal excitation, thereby producing a pronounced analgesic effect. In this study, a rat model of occlusal interference was established to induce TMD-related pain, following previously validated experimental protocol [23]. Compared with chemically or surgically induced models, this approach more accurately reproduces the chronic biomechanical stress and low-grade inflammatory microenvironment characteristic of clinical TMD [24, 25]. TMD-related pain was assessed by determining the orofacial mechanical hypersensitivity using von Frey filaments, a well-established method for evaluating pain sensitization [22]. At the same time, the anti-rat CD4 monoclonal antibody OX38 was used to deplete CD4+ T cells in this study. While CD4 is also expressed at low levels on monocytes, macrophages, and dendritic cells, its expression is most abundant on helper T lymphocytes [26]. OX38 has been extensively validated for selective CD4+ T cell depletion in rats across multiple experimental contexts, therefore, while off-target effects on CD4+ myeloid cells cannot be completely excluded, the predominant interpretation of our findings is that they reflect the functional role of CD4+ T cells [27, 28]. After modeling, rats in Groups 2 and 3 exhibited significantly increase in the mechanical hypersensitivity reaching a peak at day 6, followed by a gradual decline. Whereas, compared with Group 2, rats exhibited significantly lower pain sensitivity at all time points in Group 3. This proved that the TMD-related pain model used in this study is effective and reliable, validating the subsequent results. Interestingly, the temporal changes of cytokine expression in circulating levels displayed sequential phases of the immune response. In the early stage, the circulating levels of IL-17 A were significantly upregulated in both Group2 and Group3, along with it TMD-related pain increased. Afterwards, as TMD-related pain drops from its peak to a stable level, serum IL-17 A also drops back to no difference between groups. Finally, IL-17 A concentrations were significantly declined in both Group2 and Group3. These findings are consistent with the previous studies that there is an increase in IL-17 A in acute inflammation following trauma and IL-17 A plays a key role in the acute inflammation [29, 30]. Traditionally, it is believed that the upregulation of IL-17 A was closely related to the activation of Th17 which originated from CD4⁺ T cells [31, 32]. Contrary to expectation, depletion of CD4⁺ T cells in Group 3 seem not to impact IL-17 A activation. Beyond Th17 cells, there should be other sources contributing to IL-17 A increase. As research advanced, it became clear that various other cell types, including CD8 + T cells, γδ T cells, innate lymphoid cells (ILCs), natural killer cells, invariant natural killer T cells, mucosa-associated invariant T cells, mast cells, and Paneth cells, are capable of secreting IL-17 A [33]. We speculate that once occlusal-induced mechanical injury and multiple immune pathways have jointly established inflammation, the recruitment and activation of CD4⁺ T cells are already underway [34, 35]. Depleting CD4⁺ T cells at this stage may fail to completely block IL-17 A increase, as other pathways alone can maintain the inflammatory milieu. Therefore, IL-17 A may play a role in TMD pain through pathways that are either partially dependent or independent of CD4⁺ T cells. Elucidating these distinct mechanistic routes represents a critical avenue for future research. Unlike IL-17 A, the circulating levels of TNF-α displayed pronounced upregulation in Group2 at the end of the experiment, the same at the tissue level. These findings indicated that TNF-α is an important pro-inflammatory cytokine both in systemic and local response. Similar evidence in animal models shows that TNF-a is found at the site of injury and is still up-regulated post-injury. Increasing results have shown that TNF-α plays a key role in the pain caused by TMD via regulation of synaptic plasticity (central sensitization) and inflammatory pain, leading to an increase in pain nociception in the tissues surrounding the joint and the trigeminal ganglia [36, 37]. Depletion of CD4⁺ T cells strikingly reduced the level of TNF-α both in circulation and local TMJ tissue. However, the circulating levels of IL-6 and IFN-γ displayed no difference between the groups throughout the test period. Because TMJs are small peripheral joints, the changes of TMJs may not induce prominent changes in the systemic level in the peripheral blood. Whereas, at the tissue level, immunofluorescence analysis demonstrated pronounced local expression of IL-6, and IFN-γ, which are known to promote leukocyte infiltration, fibroblast activation, and cytokine amplification loops [36]. Although direct evidence is not provided in this study, accumulating evidence suggests that peripheral immune alterations can indirectly but powerfully influence trigeminal ganglion neurons [38–40]. TNF-α, a master regulator of inflammation, has been shown to directly sensitize trigeminal nociceptive neurons by modulating ion channel expression and excitability. Moreover, TNF-α promotes the expression of other proinflammatory cytokines within the ganglion, creating a self-perpetuating cycle that sustains neuronal hyperexcitability [41]. IL-6 can directly enhance neuronal firing rates while simultaneously activating satellite glial cells, which then release additional neuroactive substances to amplify the response via paracrine signaling [42]. IFN-γ, although less studied in the TG context, contributes to neuroimmune crosstalk by activating resident macrophages and microglia, which in turn release downstream mediators that promote central sensitization [43]. Collectively, these cytokine-mediated neuron-glia interactions create a positive feedback loop that lowers the activation threshold of trigeminal nociceptors, leading to peripheral sensitization, and facilitates the transmission of nociceptive signals to central pain-processing circuits. Therefore, the concurrent downregulation of IL-6, TNF-α and IFN-γ following CD4⁺ T cell depletion suggests re-establishing immune and neuronal homeostasis across peripheral and central levels and provides a plausible explanation for the pain relief. In addition, Cortisol, a key effector hormone of the hypothalamic–pituitary–adrenal (HPA) axis was explored. In this study, it demonstrated similarities to TNF-α in circulating levels with significantly increase in the later phase. It has been proved that persistent nociceptive input typically leads to prolonged activation of the HPA axis, and excessive cortisol may disrupt immune homeostasis and neuronal plasticity, thereby aggravating pain sensitivity [44]. Although cortisol classically suppresses inflammatory transcriptional programs, chronic or repeated HPA-axis activation can become maladaptive, such that pro-inflammatory mediators may persist despite elevated cortisol [45, 46]. A commonly proposed explanation is that prolonged stress signaling may be accompanied by attenuated biological responsiveness to endogenous glucocorticoids, weakening the control of cytokine production and permitting nociceptive and inflammatory drive to persist [47]. After depletion of CD4⁺ T cells, the decreased immune burden may have relieved the sustained stimulation of the HPA axis, restoring cortisol levels toward baseline. Because cortisol exhibits diurnal rhythm fluctuations and its secretion is not constant. Although we collected samples at the same time point during the experiment, a single test cannot accurately reflect the process of cortisol changes, and we cannot distinguish which attribute to its fluctuations. This finding may implies that immune modulation can reciprocally influence endocrine homeostasis. The nature of the relationship between CD4⁺ T cells and cortisol and HPA axis in TMD-related pain is far from elucidated and worth to explore. Indeed, this study is only a preliminary exploration of CD4⁺ T cell involved in TMD-related pain. Several limitations should be acknowledged in the present study. First, the sample size was relatively small, which may limit the statistical power and generalizability of the findings. Second, only male rats were included in the experiment. Given that TMD exhibit a well-documented female predominance in clinical populations, the exclusive use of male animals represents a significant limitation. Consequently, the current results may not fully reflect the clinical reality of TMD and should be extrapolated to female populations with caution. Moreover, a matched isotype control antibody was not included in this study, which makes it difficult to completely exclude potential nonspecific effects of antibody administration. Future investigations with larger sample sizes and the inclusion of both sexes using an appropriate isotype control are necessary to validate and extend these findings. Conclusion In conclusion, this study demonstrated systemic and local inflammatory changes and consistently lower pain sensitivity in the rat model of TMD-related pain after CD4+ T cell depletion. These findings highlight the central role of CD4⁺ T cell in the pathophysiology of TMD-related pain and suggest that targeting CD4⁺ T cells or their downstream signaling pathways may represent a promising immunomodulatory strategy for TMD-related pain management. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4 Supplementary Material 5 Supplementary Material 5 Supplementary Material 6 Supplementary Material 6 Supplementary Material 7 Supplementary Material 7 Supplementary Material 8 Supplementary Material 8 Supplementary Material 9 Supplementary Material 9 Supplementary Material 10 Supplementary Material 10 Supplementary Material 11 Supplementary Material 11 Supplementary Material 12 Supplementary Material 12